True Wealth Design’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.52K Sell
343
-284
-45% -$1.27K ﹤0.01% 1782
2026
Q2
$2.5K Buy
627
+404
+181% +$1.11K ﹤0.01% 1598
2026
Q1
$299 Buy
+223
New +$444 ﹤0.01% 2218
2025
Q4
– Sell
-45
Closed -$302 – 2814
2025
Q3
$302 Buy
45
+36
+400% +$235 ﹤0.01% 2182
2025
Q2
$53 Sell
9
-17
-65% -$111 ﹤0.01% 2369
2025
Q1
$219 Buy
+26
New +$234 ﹤0.01% 1914

Other funds holding TMCI

True Wealth Design's TMCI Position: Q3 2026 in Review

True Wealth Design reduced its Treace Medical Concepts (TMCI) stake by 45% in Q3 2026, selling an estimated $1.27K and leaving 343 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

True Wealth Design first reported a position in TMCI in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.5K in Q2 2026. 4 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • True Wealth Design held 343 shares of Treace Medical Concepts worth $1.52K as of Q3 2026.
  • True Wealth Design sold 284 Treace Medical Concepts shares in Q3 2026, an estimated $1.27K.
  • Treace Medical Concepts made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1782 holding.
  • True Wealth Design first reported a position in Treace Medical Concepts in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Treace Medical Concepts position peaked at $2.5K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.